ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49209
0.00%
Bitcoin
66,773.75
-0.46%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Inspira Technologies Oxy B H N Ltd (IINN)

  7. Inspira Technologies Oxy B H N Ltd (IINN) News

IINN

Inspira Technologies Oxy... (IINN)

Inspira Technologies Oxy B H N Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IINN
DateTimeSourceHeadlineSymbolCompany
02/05/202423:18PR Newswire (US)Inspira™ Announces Start of Production of the INSPIRA™ ART100NASDAQ:IINNInspira Technologies Oxy B H N Ltd
25/04/202422:00PR Newswire (US)Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100NASDAQ:IINNInspira Technologies Oxy B H N Ltd
16/04/202422:42PR Newswire (US)Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant ProceduresNASDAQ:IINNInspira Technologies Oxy B H N Ltd
10/04/202422:24PR Newswire (US)Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream InfectionsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/04/202423:30PR Newswire (US)Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial WombNASDAQ:IINNInspira Technologies Oxy B H N Ltd
01/04/202423:00PR Newswire (US)Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund ManagerNASDAQ:IINNInspira Technologies Oxy B H N Ltd
26/03/202400:20PR Newswire (US)Inspira™ Technologies Reports Full Year 2023 Financial ResultsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
18/03/202422:00PR Newswire (US)Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American MarketsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
12/03/202423:00PR Newswire (US)Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS IndicatorNASDAQ:IINNInspira Technologies Oxy B H N Ltd
09/03/202408:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
05/03/202408:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
05/03/202401:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
05/03/202401:20PR Newswire (US)Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within DaysNASDAQ:IINNInspira Technologies Oxy B H N Ltd
27/02/202423:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
27/02/202423:02PR Newswire (US)Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major MilestoneNASDAQ:IINNInspira Technologies Oxy B H N Ltd
27/02/202423:00PR Newswire (US)Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution AgreementsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
23/02/202401:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
22/02/202423:00PR Newswire (US)Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologiesNASDAQ:IINNInspira Technologies Oxy B H N Ltd
15/02/202401:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
14/02/202423:30PR Newswire (US)Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery SystemNASDAQ:IINNInspira Technologies Oxy B H N Ltd
13/02/202408:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
13/02/202408:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
09/02/202401:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
09/02/202401:00PR Newswire (US)Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART DeviceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
31/01/202400:40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
31/01/202400:30PR Newswire (US)Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART DevicesNASDAQ:IINNInspira Technologies Oxy B H N Ltd
10/01/202401:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
10/01/202400:30PR Newswire (US)Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market OpportunityNASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/01/202401:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/01/202400:30PR Newswire (US)Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 DeviceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
 Showing the most relevant articles for your search:NASDAQ:IINN

Your Recent History

EU
CW8
AMUNDI MSCI WORLD UCITS ...
BOV
FLRY3
FLEURY ON
LSE
RD14
Barclays.26
LATK
SWEEPUSDT
Sweeptoken
ASX
ATVCD
USOTC
DBOEY
Deutsche Boerse (PK)
NASDAQ
ECLP
BIT
UC0SEU
Unicredit Bank
LSE
MIX
Mobeus Income & Growth Vct
BIT
UC1H1D
Unicredit Bank
NYSE
NEP
NextEra Energy Partners
NASDAQ
LI
Li Auto
COIN
DIDEUR
Decentralized ID
USOTC
FRENF
PT Smartfren Telecom TBK (PK)
LSE
85XE
Bp Cap. 26
USOTC
LTMAQ
LATAM Airlines (PK)
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved